Skip to main content
Erschienen in: International Urology and Nephrology 2/2009

01.06.2009 | Nephrology - Review

Magnesium metabolism in health and disease

verfasst von: Carlos G. Musso

Erschienen in: International Urology and Nephrology | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

Magnesium (Mg) is the main intracellular divalent cation, and under basal conditions the small intestine absorbs 30–50% of its intake. Normal serum Mg ranges between 1.7–2.3 mg/dl (0.75–0.95 mmol/l), at any age. Even though eighty percent of serum Mg is filtered at the glomerulus, only 3% of it is finally excreted in the urine. Altered magnesium balance can be found in diabetes mellitus, chronic renal failure, nephrolithiasis, osteoporosis, aplastic osteopathy, and heart and vascular disease. Three physiopathologic mechanisms can induce Mg deficiency: reduced intestinal absorption, increased urinary losses, or intracellular shift of this cation. Intravenous or oral Mg repletion is the main treatment, and potassium-sparing diuretics may also induce renal Mg saving. Because the kidney has a very large capacity for Mg excretion, hypermagnesemia usually occurs in the setting of renal insufficiency and excessive Mg intake. Body excretion of Mg can be enhanced by use of saline diuresis, furosemide, or dialysis depending on the clinical situation.
Literatur
1.
Zurück zum Zitat Belorin Font E (2007) Magnesio. In: Ayus C, Caramelo C, Tejedor A (eds) Agua, electrolitos y equilibrio ácido-base. Panamericana, Buenos Aires, pp 293–294 Belorin Font E (2007) Magnesio. In: Ayus C, Caramelo C, Tejedor A (eds) Agua, electrolitos y equilibrio ácido-base. Panamericana, Buenos Aires, pp 293–294
2.
Zurück zum Zitat Belorin Font E (2007) Hipomagnesemia e hipermagnesemia. In: Ayus C, Caramelo C, Tejedor A (eds) Agua, electrolitos y equilibrio ácido-base. Panamericana, Buenos Aires, pp 341–344 Belorin Font E (2007) Hipomagnesemia e hipermagnesemia. In: Ayus C, Caramelo C, Tejedor A (eds) Agua, electrolitos y equilibrio ácido-base. Panamericana, Buenos Aires, pp 341–344
3.
Zurück zum Zitat Kelepouris E, Agus Z (1998) Hypomagnesemia: renal magnesium handling. Semin nephrol 18:58–73PubMed Kelepouris E, Agus Z (1998) Hypomagnesemia: renal magnesium handling. Semin nephrol 18:58–73PubMed
4.
Zurück zum Zitat Rude R, Gruber H, Wei L, Frausto A, Mills B (2003) Magnesium deficiency: effect on bone and mineral metabolism in the mouse. Calcif Tissue Int. 72:32–41PubMedCrossRef Rude R, Gruber H, Wei L, Frausto A, Mills B (2003) Magnesium deficiency: effect on bone and mineral metabolism in the mouse. Calcif Tissue Int. 72:32–41PubMedCrossRef
5.
Zurück zum Zitat Graham LA, Caesar JJ, Burgen ASV (1960) Gastrointestinal absorption and excretion of magnesium in man. Metabolism 9:646–659 Graham LA, Caesar JJ, Burgen ASV (1960) Gastrointestinal absorption and excretion of magnesium in man. Metabolism 9:646–659
6.
Zurück zum Zitat Rude R (1996) Magnesium disorders. In: Kokko J, Tannen R (eds) Fluids and electrolytes. Saunders Company, W.B. Philadelphia, pp 421–445 Rude R (1996) Magnesium disorders. In: Kokko J, Tannen R (eds) Fluids and electrolytes. Saunders Company, W.B. Philadelphia, pp 421–445
7.
Zurück zum Zitat Spiegel D (2007) The role of magnesium binders in chronic kidney disease. Semin dial 20(4):333–336PubMedCrossRef Spiegel D (2007) The role of magnesium binders in chronic kidney disease. Semin dial 20(4):333–336PubMedCrossRef
8.
Zurück zum Zitat Yu A (2004) Renal transport of calcium, magnesium and phosphate. In: Brenner B (ed) Brenner & Rector’s The kidney. Saunders, Philadelphia, pp 535–571 Yu A (2004) Renal transport of calcium, magnesium and phosphate. In: Brenner B (ed) Brenner & Rector’s The kidney. Saunders, Philadelphia, pp 535–571
9.
Zurück zum Zitat Kaplan N, Palmer B, Sakhaee K, Gonzalez G (1999) Update on renal osteodystrophy: pathogenesis and clinical management. Am J Med Sci 317(4):251–260CrossRef Kaplan N, Palmer B, Sakhaee K, Gonzalez G (1999) Update on renal osteodystrophy: pathogenesis and clinical management. Am J Med Sci 317(4):251–260CrossRef
10.
Zurück zum Zitat Guyton A, Hall J (2002) Manual de Fisiología Médica. McGraw–Hill, Interamericana, Madrid Guyton A, Hall J (2002) Manual de Fisiología Médica. McGraw–Hill, Interamericana, Madrid
11.
Zurück zum Zitat Wen SF, Evanson RL, Dirks JH (1970) Micropuncture study of renal magnesium transport in proximal and distal tubule of dog. Am J Physiol 219:570–576PubMed Wen SF, Evanson RL, Dirks JH (1970) Micropuncture study of renal magnesium transport in proximal and distal tubule of dog. Am J Physiol 219:570–576PubMed
12.
Zurück zum Zitat Brunette MG, Vigneault N, Carriere S (1974) Micropuncture study of magnesium transport along the nephron in the young rat. Am J Physiol 227:891–896PubMed Brunette MG, Vigneault N, Carriere S (1974) Micropuncture study of magnesium transport along the nephron in the young rat. Am J Physiol 227:891–896PubMed
13.
Zurück zum Zitat Shareghi GR, Agus ZS (1982) Magnesium transport in the cortical thick ascending limb of Henle’s loop of the rabbit. J Clin invest 69:759–769PubMedCrossRef Shareghi GR, Agus ZS (1982) Magnesium transport in the cortical thick ascending limb of Henle’s loop of the rabbit. J Clin invest 69:759–769PubMedCrossRef
14.
Zurück zum Zitat Riccardi D, Hall AE, Chattopadhyay N et al (1998) Localization of the extracellular calcium sensing protein in the rat kidney. Am J Physiol 274:F611–F622PubMed Riccardi D, Hall AE, Chattopadhyay N et al (1998) Localization of the extracellular calcium sensing protein in the rat kidney. Am J Physiol 274:F611–F622PubMed
15.
Zurück zum Zitat Macías Núñez JF, Cameron S (2006) Renal function in the elderly. In: Cameron S (ed) Oxford textbook of clinical nephrology. Oxford University Press, Oxford Macías Núñez JF, Cameron S (2006) Renal function in the elderly. In: Cameron S (ed) Oxford textbook of clinical nephrology. Oxford University Press, Oxford
16.
Zurück zum Zitat Musso CG, Macías Núñez JF (2008) Renal acidification, calcium, phosphate and magnesium. In: Macías Núñez JF, Cameron S, Oreopoulos D (eds) Renal ageing: health and disease. Springer, New York, pp 155–171CrossRef Musso CG, Macías Núñez JF (2008) Renal acidification, calcium, phosphate and magnesium. In: Macías Núñez JF, Cameron S, Oreopoulos D (eds) Renal ageing: health and disease. Springer, New York, pp 155–171CrossRef
17.
Zurück zum Zitat Quamme GA (1982) Effect of hypercalcemia on renal tubular handling of calcium and magnesium. Can J Physiol Pharmacol 60:1275–1280PubMed Quamme GA (1982) Effect of hypercalcemia on renal tubular handling of calcium and magnesium. Can J Physiol Pharmacol 60:1275–1280PubMed
18.
Zurück zum Zitat Millane TA, Ward DE, Camm AJ (1992) Electrophysiology, pacing and arrhythmia. Clin Cardiol 15:103–108PubMedCrossRef Millane TA, Ward DE, Camm AJ (1992) Electrophysiology, pacing and arrhythmia. Clin Cardiol 15:103–108PubMedCrossRef
19.
20.
Zurück zum Zitat Braden GL, Germain MJ, Fitzgibbons JP (1985) Impaired potassium and magnesium homeostasis in acute tubulo-interstitial nephritis. Nephron 41:273–278PubMedCrossRef Braden GL, Germain MJ, Fitzgibbons JP (1985) Impaired potassium and magnesium homeostasis in acute tubulo-interstitial nephritis. Nephron 41:273–278PubMedCrossRef
21.
Zurück zum Zitat Mason J (1990) Renal side-effects of cyclosporine. Transplant proc 22:1280–1283PubMed Mason J (1990) Renal side-effects of cyclosporine. Transplant proc 22:1280–1283PubMed
22.
Zurück zum Zitat Rude RK (1993) Magnesium metabolism and deficiency. Endocrinol Metab Clin North Am 22:377–395PubMed Rude RK (1993) Magnesium metabolism and deficiency. Endocrinol Metab Clin North Am 22:377–395PubMed
23.
Zurück zum Zitat Eisenbud E, LoBue CC (1976) Hypocalcemia after therapeutic use of magnesium sulphate. Arch Intern Med 136:688–691PubMedCrossRef Eisenbud E, LoBue CC (1976) Hypocalcemia after therapeutic use of magnesium sulphate. Arch Intern Med 136:688–691PubMedCrossRef
24.
Zurück zum Zitat Navarro J, Oster JR, Gknosos PJ et al (1991) Tetany induced on separate occasions by administration of potassium and magnesium in a patient with hungry-bone syndrome. Miner Electrolyte Metab 17:340–344PubMed Navarro J, Oster JR, Gknosos PJ et al (1991) Tetany induced on separate occasions by administration of potassium and magnesium in a patient with hungry-bone syndrome. Miner Electrolyte Metab 17:340–344PubMed
25.
Zurück zum Zitat Bundy JT, Connito D, Mahoney MD et al (1995) Treatment of idiopathic renal magnesium wasting with amiloride. Am J Nephrol 15:75–77PubMedCrossRef Bundy JT, Connito D, Mahoney MD et al (1995) Treatment of idiopathic renal magnesium wasting with amiloride. Am J Nephrol 15:75–77PubMedCrossRef
26.
Zurück zum Zitat Devane J, Ryan MP (1981) The effects of amiloride and triamterene on urinary magnesium excretion in conscious saline-loaded rats. Br J Pharmacol 72:285–289PubMed Devane J, Ryan MP (1981) The effects of amiloride and triamterene on urinary magnesium excretion in conscious saline-loaded rats. Br J Pharmacol 72:285–289PubMed
27.
Zurück zum Zitat Christiansen C, Baastrup PC, Transbol L (1976) Lithium, hypercalcemia, hypermagnesemia, and hyperparathyroidism (letter). Lancet 2:969PubMedCrossRef Christiansen C, Baastrup PC, Transbol L (1976) Lithium, hypercalcemia, hypermagnesemia, and hyperparathyroidism (letter). Lancet 2:969PubMedCrossRef
28.
Zurück zum Zitat Alfrey A (1996) Disorders of magnesium metabolism. In: Bennett JC, Plum F (eds) Cecil textbook of medicine. WB Saunders Company, Philadelphia, pp 1137–1138 Alfrey A (1996) Disorders of magnesium metabolism. In: Bennett JC, Plum F (eds) Cecil textbook of medicine. WB Saunders Company, Philadelphia, pp 1137–1138
29.
Zurück zum Zitat Atabek M, Kurtoglu S, Pirgon O (2006) Possible effect of leptin on renal magnesium excretion in adolescent patients with type 1 diabetes. Pediatrics Int 48:393–397CrossRef Atabek M, Kurtoglu S, Pirgon O (2006) Possible effect of leptin on renal magnesium excretion in adolescent patients with type 1 diabetes. Pediatrics Int 48:393–397CrossRef
30.
Zurück zum Zitat Delfini E, Petramala L, Caliumi C, Cotesta D, De Toma G, Cavallaro G, Panzironi G, Diacinti D, Mimisola S, DÉrasmo E, Mazzuoli G, Letizia C (2007) Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism. Metab Clin Exp 56:30–36PubMed Delfini E, Petramala L, Caliumi C, Cotesta D, De Toma G, Cavallaro G, Panzironi G, Diacinti D, Mimisola S, DÉrasmo E, Mazzuoli G, Letizia C (2007) Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism. Metab Clin Exp 56:30–36PubMed
31.
Zurück zum Zitat Massey L (2005) Magnesium therapy for nephrolithiasis. Magnes Res 18(2):123–126PubMed Massey L (2005) Magnesium therapy for nephrolithiasis. Magnes Res 18(2):123–126PubMed
32.
Zurück zum Zitat Rude R, Gruber H, Norton J, Wei L, Frausto A, Kilbum J (2005) Dietary magnesium reduction to 25% of nutrient requirement disrupts boné and mineral metabolism in the rat. Bone 37:211–219PubMedCrossRef Rude R, Gruber H, Norton J, Wei L, Frausto A, Kilbum J (2005) Dietary magnesium reduction to 25% of nutrient requirement disrupts boné and mineral metabolism in the rat. Bone 37:211–219PubMedCrossRef
33.
Zurück zum Zitat D’Hase P, Couttenye M, Lamberts L, Elseviers M, Goodman W, Schrooten I, Cabrera W, De Broe M (1999) Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients. Clin Chem 45(9):1548–1556 D’Hase P, Couttenye M, Lamberts L, Elseviers M, Goodman W, Schrooten I, Cabrera W, De Broe M (1999) Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients. Clin Chem 45(9):1548–1556
34.
Zurück zum Zitat Ng A, Hercz G, Kandel R, Grynpas M (2004) Association between fluoride, magnesium, aluminium and bone quality in renal osteodystrophy. Bone 34:216–224PubMedCrossRef Ng A, Hercz G, Kandel R, Grynpas M (2004) Association between fluoride, magnesium, aluminium and bone quality in renal osteodystrophy. Bone 34:216–224PubMedCrossRef
35.
Zurück zum Zitat Ersoy F (2007) Osteoporosis in the elderly with chronic kidney disease. Int Urol Nephrol 39:321–331PubMedCrossRef Ersoy F (2007) Osteoporosis in the elderly with chronic kidney disease. Int Urol Nephrol 39:321–331PubMedCrossRef
36.
Zurück zum Zitat Port F, Young E (1996) Fluids and electrolyte disorders in dialysis. In: Kokko J, Tannen R (eds) Fluids and electrolytes. Saunders Company, Philadelphia, pp 533–560 Port F, Young E (1996) Fluids and electrolyte disorders in dialysis. In: Kokko J, Tannen R (eds) Fluids and electrolytes. Saunders Company, Philadelphia, pp 533–560
37.
Zurück zum Zitat Feriani M, Catizone L, Fracasso A (2000) Peritoneal dialysis solutions and systems. In: Gokal R, Khanna R, Krediet R, Nolph K (eds) Textbook of peritoneal dialysis. Kluwer Academic Publishers, Dordrecht, pp 253–305 Feriani M, Catizone L, Fracasso A (2000) Peritoneal dialysis solutions and systems. In: Gokal R, Khanna R, Krediet R, Nolph K (eds) Textbook of peritoneal dialysis. Kluwer Academic Publishers, Dordrecht, pp 253–305
38.
Zurück zum Zitat Navarro J, Mora C, Jiménez A, Ci B, Torres A, Macías M, García J (1999) Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients. Am J Kidney Dis 34(1):43–48PubMedCrossRef Navarro J, Mora C, Jiménez A, Ci B, Torres A, Macías M, García J (1999) Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients. Am J Kidney Dis 34(1):43–48PubMedCrossRef
39.
Zurück zum Zitat Alon I, Gorelik O, Berman S, Almoznino-Sarafian D, Shteinshnaider M, Weissgarten J, Modai D, Cohen N (2006) Intracellular magnesium in elderly patients with heart failure: effects of diabetes and renal dysfunction. J Trace Elem Med Biol 20:221–226PubMedCrossRef Alon I, Gorelik O, Berman S, Almoznino-Sarafian D, Shteinshnaider M, Weissgarten J, Modai D, Cohen N (2006) Intracellular magnesium in elderly patients with heart failure: effects of diabetes and renal dysfunction. J Trace Elem Med Biol 20:221–226PubMedCrossRef
40.
Zurück zum Zitat García-Casasola G, Sánchez-Hernández C, Luengo Pierrad P, Arenas González S, Bilbao Garay J, Zapatero Gaviria A (2004) Hipomagnesemia e insuficiencia cardíaca. Rev Clin Esp 1:43–47 García-Casasola G, Sánchez-Hernández C, Luengo Pierrad P, Arenas González S, Bilbao Garay J, Zapatero Gaviria A (2004) Hipomagnesemia e insuficiencia cardíaca. Rev Clin Esp 1:43–47
41.
Zurück zum Zitat Ceremuzynski L, Gebalska J, Wolk R, Makowska E (2000) Hipomagnesemia in Herat failure with ventricular arrhythmias. Beneficial effects of magnesium supplementation. J Int Med 247:78–86CrossRef Ceremuzynski L, Gebalska J, Wolk R, Makowska E (2000) Hipomagnesemia in Herat failure with ventricular arrhythmias. Beneficial effects of magnesium supplementation. J Int Med 247:78–86CrossRef
Metadaten
Titel
Magnesium metabolism in health and disease
verfasst von
Carlos G. Musso
Publikationsdatum
01.06.2009
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 2/2009
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-009-9548-7

Weitere Artikel der Ausgabe 2/2009

International Urology and Nephrology 2/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.